Literature DB >> 24729399

BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis.

Eleana Ntatsaki1, David Carruthers2, Kuntal Chakravarty2, David D'Cruz2, Lorraine Harper2, David Jayne2, Raashid Luqmani2, John Mills2, Janice Mooney2, Michael Venning2, Richard A Watts3.   

Abstract

Entities:  

Keywords:  cyclophosphamide; guideline; management; rituximab; vasculitis

Mesh：

Substances：

Year:  2014        PMID： 24729399     DOI： 10.1093/rheumatology/ket445

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  67 in total

Review 1.  ANCA-associated vasculitis.

Authors:  Max Yates; Richard Watts
Journal:  Clin Med (Lond)       Date:  2017-02       Impact factor: 2.659

Review 2.  Rituximab in ANCA-Associated Vasculitis.

Authors:  Romina I Hassan; Angelo L Gaffo
Journal:  Curr Rheumatol Rep       Date:  2017-02       Impact factor: 4.592

Review 3.  [Treatment strategies for ANCA-associated vasculitides].

Authors:  B Hellmich
Journal:  Z Rheumatol       Date:  2015-06       Impact factor: 1.372

Review 4.  [Current guidelines on ANCA-associated vasculitides : Common features and differences].

Authors:  B Hellmich
Journal:  Z Rheumatol       Date:  2017-03       Impact factor: 1.372

Review 5.  Interstital lung disease in ANCA vasculitis.

Authors:  Marco A Alba; Luis Felipe Flores-Suárez; Ashley G Henderson; Hong Xiao; Peiqi Hu; Patrick H Nachman; Ronald J Falk; J Charles Jennette
Journal:  Autoimmun Rev       Date:  2017-05-04       Impact factor: 9.754

6.  Cogan's syndrome with pyoderma gangrenosum: management of two uncommon disorders with aggressive presentation in a patient.

Authors:  Ezolene Pei-Chin Chua; Richard B Mallett; Sandeep Dahiya
Journal:  BMJ Case Rep       Date:  2018-06-19

7.  Renal-limited vasculitis with elevated levels of multiple antibodies.

Authors:  Noriaki Sato; Hideki Yokoi; Hirotaka Imamaki; Eiichiro Uchino; Kaoru Sakai; Takeshi Matsubara; Tatsuo Tsukamoto; Sachiko Minamiguchi; Motoko Yanagita
Journal:  CEN Case Rep       Date:  2017-03-03

Review 8.  Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity.

Authors:  Eleni I Kampylafka; Harry Alexopoulos; Marinos C Dalakas; Athanasios G Tzioufas
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 9.  Pathogenesis and treatment of ANCA-associated vasculitis-a role for complement.

Authors:  Damien Noone; Diane Hebert; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2016-09-05       Impact factor: 3.714

10.  An update on the general management approach to common vasculitides.

Authors:  Mooikhin Hng; Sizheng S Zhao; Robert J Moots
Journal:  Clin Med (Lond)       Date:  2020-11       Impact factor: 2.659
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.